[go: up one dir, main page]

CA3019312A1 - Compositions visant a reduire les taux de lipides sanguins et leurs procedes de fabrication - Google Patents

Compositions visant a reduire les taux de lipides sanguins et leurs procedes de fabrication Download PDF

Info

Publication number
CA3019312A1
CA3019312A1 CA3019312A CA3019312A CA3019312A1 CA 3019312 A1 CA3019312 A1 CA 3019312A1 CA 3019312 A CA3019312 A CA 3019312A CA 3019312 A CA3019312 A CA 3019312A CA 3019312 A1 CA3019312 A1 CA 3019312A1
Authority
CA
Canada
Prior art keywords
oil
phytosterol
monascus
component
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA3019312A
Other languages
English (en)
Inventor
Anguo Li
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jk & Bestin Enterprise Ltd
Original Assignee
Jk & Bestin Enterprise Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jk & Bestin Enterprise Ltd filed Critical Jk & Bestin Enterprise Ltd
Priority to CA3019312A priority Critical patent/CA3019312A1/fr
Publication of CA3019312A1 publication Critical patent/CA3019312A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • A23L33/11Plant sterols or derivatives thereof, e.g. phytosterols
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23DEDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
    • A23D9/00Other edible oils or fats, e.g. shortenings or cooking oils
    • A23D9/007Other edible oils or fats, e.g. shortenings or cooking oils characterised by ingredients other than fatty acid triglycerides
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23DEDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
    • A23D9/00Other edible oils or fats, e.g. shortenings or cooking oils
    • A23D9/007Other edible oils or fats, e.g. shortenings or cooking oils characterised by ingredients other than fatty acid triglycerides
    • A23D9/013Other fatty acid esters, e.g. phosphatides
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L31/00Edible extracts or preparations of fungi; Preparation or treatment thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • A61K31/366Lactones having six-membered rings, e.g. delta-lactones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06Fungi, e.g. yeasts
    • A61K36/062Ascomycota
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14Fungi; Culture media therefor

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nutrition Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA3019312A 2018-10-01 2018-10-01 Compositions visant a reduire les taux de lipides sanguins et leurs procedes de fabrication Abandoned CA3019312A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA3019312A CA3019312A1 (fr) 2018-10-01 2018-10-01 Compositions visant a reduire les taux de lipides sanguins et leurs procedes de fabrication

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA3019312A CA3019312A1 (fr) 2018-10-01 2018-10-01 Compositions visant a reduire les taux de lipides sanguins et leurs procedes de fabrication

Publications (1)

Publication Number Publication Date
CA3019312A1 true CA3019312A1 (fr) 2019-01-23

Family

ID=65037671

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3019312A Abandoned CA3019312A1 (fr) 2018-10-01 2018-10-01 Compositions visant a reduire les taux de lipides sanguins et leurs procedes de fabrication

Country Status (1)

Country Link
CA (1) CA3019312A1 (fr)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109699887A (zh) * 2019-01-24 2019-05-03 山西潞安石圪节智华生物科技有限公司 一种牡丹籽油降血脂软胶囊及其制备方法
CN111513155A (zh) * 2020-05-21 2020-08-11 云南中医药大学 一种防治脂代谢异常的组合物
CN111803597A (zh) * 2020-08-20 2020-10-23 西藏月王药诊生态藏药科技有限公司 一种青稞红曲颗粒剂及其制备方法
CN113455552A (zh) * 2021-07-22 2021-10-01 上海太太乐食品有限公司 一种健康浓香食用油及其制备方法
CN116035210A (zh) * 2022-12-30 2023-05-02 广州白云山汉方现代药业有限公司 一种解决内容物分层的方法及其在植物甾醇酯红曲软胶囊制备上的应用
CN116087402A (zh) * 2022-12-30 2023-05-09 广州白云山汉方现代药业有限公司 一种植物甾醇酯红曲软胶囊中同时测定多种游离甾醇与莫拉可林k含量的检测方法

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109699887A (zh) * 2019-01-24 2019-05-03 山西潞安石圪节智华生物科技有限公司 一种牡丹籽油降血脂软胶囊及其制备方法
CN109699887B (zh) * 2019-01-24 2022-02-22 山西潞安矿业(集团)有限责任公司 一种牡丹籽油降血脂软胶囊及其制备方法
CN111513155A (zh) * 2020-05-21 2020-08-11 云南中医药大学 一种防治脂代谢异常的组合物
CN111513155B (zh) * 2020-05-21 2022-11-08 云南中医药大学 一种防治脂代谢异常的组合物
CN111803597A (zh) * 2020-08-20 2020-10-23 西藏月王药诊生态藏药科技有限公司 一种青稞红曲颗粒剂及其制备方法
CN113455552A (zh) * 2021-07-22 2021-10-01 上海太太乐食品有限公司 一种健康浓香食用油及其制备方法
CN116035210A (zh) * 2022-12-30 2023-05-02 广州白云山汉方现代药业有限公司 一种解决内容物分层的方法及其在植物甾醇酯红曲软胶囊制备上的应用
CN116087402A (zh) * 2022-12-30 2023-05-09 广州白云山汉方现代药业有限公司 一种植物甾醇酯红曲软胶囊中同时测定多种游离甾醇与莫拉可林k含量的检测方法
CN116087402B (zh) * 2022-12-30 2025-01-24 广州白云山汉方现代药业有限公司 一种植物甾醇酯红曲软胶囊中同时测定多种游离甾醇与莫拉可林k含量的检测方法

Similar Documents

Publication Publication Date Title
CA3019312A1 (fr) Compositions visant a reduire les taux de lipides sanguins et leurs procedes de fabrication
CA2430315C (fr) Complement servant faire diminuer le taux de cholesterol
US7517540B2 (en) Cranberry seed oil extract and compositions containing components thereof
US8895079B2 (en) Combinations of botanical extracts for promoting cardiovascular health
WO2007113748A1 (fr) Formulation orale présentant des effets cardiovasculaires bénéfiques comprenant de la berbérine
JP4686173B2 (ja) ポリフェノールおよび/またはビタミンcを含有するアセロラ処理物
AU2013320237A1 (en) Novel extracts of Cynara scolymus, Coffea spp. and Olea europaea for the treatment of metabolic syndrome
Bagabaldo et al. ‘Saba’banana (Musa acuminata x balbisiana BBB Group) peel pectin supplementation improves biomarkers of obesity and associated blood lipid disorders in obese hypercholesterolemic mice
Zeng et al. Anti-lipid-oxidation effects and edible safety evaluation of the oil extracted by a supercritical CO2 process from coix seed fermented by Monascus purpureus
Mohamed et al. Chia seeds oil enriched with phytosterols and mucilage as a cardioprotective dietary supplement towards inflammation, oxidative stress, and dyslipidemia
Hoi et al. Sorghum distillers dried grain lipid extract increases cholesterol excretion and decreases plasma and liver cholesterol concentration in hamsters
CN110520115A (zh) 用于治疗心血管疾病的组合物
AU2006347122B2 (en) Antiobesity composition containing component originating in the bark of tree belonging to the genus Acacia
CN1672712A (zh) 降低血脂的新组方及其制剂制备方法
WO2012115026A1 (fr) Composition contenant du tomatoside a
Kumar et al. Deciphering functional characteristics and in-vitro bioactive properties of banana central core stem powder
CN106912952A (zh) 一种具有降血脂功能的药物组合物及其胶囊制剂的制备方法
TWI359667B (en) Formulation for oral administration having a healt
KR20170030641A (ko) 항이상지질혈증 활동성을 갖는 식이요법용 조성물
JP2009203209A (ja) アカシア属樹皮由来物を含有する血糖降下及び/又は抗肥満組成物
M'Rabet et al. A Comprehensive Review on Chemistry, Nutritional Relevance, and Potential Applications of Coriandrum sativum L. Waste/By-Products
Sharmin et al. Effect of ethanol extract of glycine max (soy bean) On serum lipid profile of fat-fed hyperlipidemic rats
Althwab Ability of crude lipid, wax, and oil fractions extracted from red grain sorghum whole kernel to prevent high cholesterol caused by high-fat diets in a hamster model
CN104274575B (zh) 一种具有降脂作用的组合物及其制备方法和用途
KR101428521B1 (ko) 울금 발효물을 유효성분으로 함유하는 비알코올성 지방간 예방 및 치료용 조성물

Legal Events

Date Code Title Description
FZDE Discontinued

Effective date: 20200916